Spastic Paraplegia 35, Autosomal Recessive, with or Without Neurodegeneration (SPG35)

Alias:

Fatty Acid Hydroxylase-Associated Neurodegeneration

Fahn

Spg35

Leukodystrophy, Dysmyelinating, and Spastic Paraparesis with or Without Dystonia

Spastic Paraplegia 35, Autosomal Recessive

Spastic Paraplegia 35

Leukodystrophy Dysmyelinating and Spastic Paraparesis with or Without Dystonia

Dysmyelinating Leukodystrophy and Spastic Paraparesis

Paraplegia, Spastic, Autosomal Recessive, Type 35

Hereditary Spastic Paraplegia 35

Spastic Paraplegia-35

加入收藏

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Spastic Paraplegia 35, Autosomal Recessive, with or Without Neurodegeneration, also known as fatty acid hydroxylase-associated neurodegeneration, is related to hereditary spastic paraplegia 35 and hereditary spastic paraplegia, and has symptoms including ataxia, seizures and urgency of micturition. An important gene associated with Spastic Paraplegia 35, Autosomal Recessive, with or Without Neurodegeneration is FA2H (Fatty Acid 2-Hydroxylase). The drug Iron has been mentioned in the context of this disorder. Affiliated tissues include globus pallidus and eye, and related phenotypes are mental deterioration and loss of ambulation

Related ID：

MALACARDS：SPS241

OMIM：612319

MESH：D015419